82 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
incapable of exercise (other than by reason of the satisfaction thereof) shall not be included (to the extent that the relevant award has lapsed … ceases to be Connected for one of the following reasons:
death;
disability, injury or ill health (evidenced to the satisfaction of the Board
8-K
EX-10.2
qdo3yj o5h
29 Jun 23
Departure of Directors or Certain Officers
4:25pm
8-K
EX-10.1
wmimsl13sgmzetw0 xi
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
425
5ymsppe21w6kwg
30 May 23
Business combination disclosure
4:21pm
8-K
a33nla j7nuqx9j6e4xg
30 May 23
Submission of Matters to a Vote of Security Holders
4:18pm
425
f950gkpm7aa l6ci9b
22 May 23
Business combination disclosure
7:01am
8-K
sip62sw 7m3fvi73s0j3
22 May 23
Other Events
6:59am
8-K
EX-99.1
4mjcfc
12 May 23
Adaptimmune Reports First Quarter Financial Results and Business Update
7:36am
424B3
qmm5wzg de
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
wfvwmm0m83 lzb
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
11yk21fzg3 z1rrn
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm